'Safety signals' may help slow down anxiety
Researchers at Yale University and Weill Cornell Medicine report Dec. 9 on a novel way that could help combat such anxiety: When life triggers excessive fear, use a safety signal.
In humans and in mice, a symbol or a sound that is never associated with adverse events can relieve anxiety through an entirely different brain network than that activated by existing behavioral therapy, the researchers write in the journal Proceedings of the National Academy of Sciences.
“A safety signal could be a musical piece, a person, or even an item like a stuffed animal that represents the absence of threat,” said Paola Odriozola, Ph.D. candidate in psychology at Yale and co-first author.
The approach differs from behavioral therapy, which slowly exposes patients to the source of their fear, such as spiders, until a patient learns that spiders do not represent a significant threat and anxiety is decreased. And for many people, exposure-based therapy does not truly help.
The new study may explain why.
In the new research, subjects were conditioned to associate one shape with a threatening outcome and a different shape with a non-threatening outcome. (In mice, tones were used in the conditioning instead of shapes.) The shape associated with threat alone was presented to subjects, and later subjects viewed both threatening and non-threatening shape together. Adding the second, non-threatening shape — the safety signal — suppressed the subjects’ fear compared to the response to the threat-related shape alone. Brain imaging studies of both human and mice subjects presented with the signals showed this approach activated a different neural network than exposure therapy, suggesting safety signaling might be an effective way to augment current therapies.
“Exposure-based therapy relies on fear extinction, and although a safety memory is formed during therapy, it is always competing with the previous threat memory,” explained Dylan Gee, assistant professor of psychology at Yale and co-senior author. “This competition makes current therapies subject to the relapse of fear — but there is never a threat memory associated with safety signals.”
Gee stressed that the need for alternatives for those suffering from anxiety-related disorders is great.
“Both cognitive behavioral therapy and antidepressants can be highly effective, but a substantial part of the population does not benefit sufficiently, or the benefits they experience don’t hold up in the longer term,” she said.
Heidi Meyer of Weill Cornell Medicine is a co-first author of the paper and Francis Lee of Weill is co-senior author. The research was primarily funded by the National Institutes of Health, the Brain & Behavior Research Foundation, the Jacobs Foundation, the Pritzker Neuropsychiatric Disorders Research Consortium, the New York-Presbyterian Youth Anxiety Center, the Dr. Mortimer D. Sackler family, the DeWitt-Wallace Fund of the New York Community Trust, and the National Science Foundation.